101
Views
3
CrossRef citations to date
0
Altmetric
Original Research

The efficacy of extrafine beclomethasone dipropionate–formoterol fumarate in COPD patients who are not “frequent exacerbators”: a post hoc analysis of the FORWARD study

, , &
Pages 3263-3271 | Published online: 03 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Luca Richeldi, Alessio Piraino, Francesco Macagno, Gianluigi Micarelli & Eleonora Ingrassia. (2021) The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease (COPD) in an Italian Context of Real Life: The TRITRIAL Study Protocol. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 159-166.
Read now
Simon Wan Yau Ming, John Haughney, Dermot Ryan, Iain Small, Federico Lavorini, Alberto Papi, Dave Singh, David M G Halpin, John R Hurst, Shishir Patel, Matthias Ochel, Janwillem Kocks, Victoria Carter, Antony Hardjojo & David B Price. (2020) A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3093-3103.
Read now
Jean Bourbeau, Mohit Bhutani, Paul Hernandez, Shawn D. Aaron, Meyer Balter, Marie-France Beauchesne, Anthony D’Urzo, Roger Goldstein, Alan Kaplan, François Maltais, Don D. Sin & Darcy D. Marciniuk. (2019) Canadian Thoracic Society Clinical Practice Guideline on pharmacotherapy in patients with COPD – 2019 update of evidence. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 3:4, pages 210-232.
Read now